Recent studies have demonstrated that CLR is associated with tumors, postoperative infections, COVID-19, acute pancreatitis, dilated cardiomyopathy, and myocardial infarction, highlighting its potential as an emerging inflammatory marker in a range of inflammatory and immune-related diseases (14–19). The gene discussed is DCLK3; the disease is infection.